Cargando…
经皮冷冻治疗644例肺癌的常见并发症分析及处理
BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after per...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000546/ https://www.ncbi.nlm.nih.gov/pubmed/20704828 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16 |
_version_ | 1783331763392610304 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after percutaneous cryoablation when applied to advanced lung cancer. METHODS: Total 644 lung cancer patients had been treated with percutaneous cryoablation guided by ultrasound and/or CT scan. The cardivascular and respiratory complications were monitored. RESULTS: Complications were relatively minor and could be controlled with routine methods. Serious complications included cardiac arrest and hemopneumothorax, and thus preventative steps should be taken. CONCLUSION: Percutaneous cryoablation for lung cancer is a simple, effective and relatively safe method, but attention should be paid to the possible complications during cryoablation. |
format | Online Article Text |
id | pubmed-6000546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60005462018-07-06 经皮冷冻治疗644例肺癌的常见并发症分析及处理 Zhongguo Fei Ai Za Zhi 短篇报道 BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after percutaneous cryoablation when applied to advanced lung cancer. METHODS: Total 644 lung cancer patients had been treated with percutaneous cryoablation guided by ultrasound and/or CT scan. The cardivascular and respiratory complications were monitored. RESULTS: Complications were relatively minor and could be controlled with routine methods. Serious complications included cardiac arrest and hemopneumothorax, and thus preventative steps should be taken. CONCLUSION: Percutaneous cryoablation for lung cancer is a simple, effective and relatively safe method, but attention should be paid to the possible complications during cryoablation. 中国肺癌杂志编辑部 2010-08-20 /pmc/articles/PMC6000546/ /pubmed/20704828 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16 Text en 版权所有©《中国肺癌杂志》编辑部2010 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 短篇报道 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title_full | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title_fullStr | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title_full_unstemmed | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title_short | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
title_sort | 经皮冷冻治疗644例肺癌的常见并发症分析及处理 |
topic | 短篇报道 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000546/ https://www.ncbi.nlm.nih.gov/pubmed/20704828 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16 |
work_keys_str_mv | AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ |